Taiwan FDA registration 3dee28b3ef67d15337eac0cbfc3961d0
“DAKO” PD-L1 IHC 28-8 pharmDx
TW: “達克” PD-L1免疫組織化學染色28-8檢測套組
Taiwan·Risk Class 3·MD·Agilent Technologies, Inc.·Registered Feb 16, 2017 – Feb 16, 2027ActiveRegistration details
- Analysis ID
- 3dee28b3ef67d15337eac0cbfc3961d0
- License Form
- Ministry of Health Medical Device Import No. 029492
- Customs Code
- DHA05602949205
Company information
- Manufacturer
- Agilent Technologies, Inc.
- Manufacturer Country
- United States
- Authorized Representative
- SCN TRADING COMPANY LIMITED
Product details
- Intended Use
- New performance: detailed as approved Chinese instructions. Performance: Details as detailed in the approved Chinese specification.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B1860 Immunopathological histochemical reagents and kits
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Feb 16, 2017
- Expiry Date
- Feb 16, 2027
About this record
Access comprehensive regulatory information for “DAKO” PD-L1 IHC 28-8 pharmDx in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 3dee28b3ef67d15337eac0cbfc3961d0 and manufactured by Agilent Technologies, Inc.. The authorized representative in Taiwan is SCN TRADING COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices